Table 2.
Author | N | Schema | Results |
---|---|---|---|
Souhami et al. (2004) | 203 | 60 Gy RT versus 60 Gy RT+SRS, both with concurrent BCNU | No difference in median survival |
Buckner et al. (2006) | 401 | 64.8 Gy RT versus accelerated RT, both with BCNU +/− cisplatin | No improvement in survival with accelerated RT or addition of cisplatin |
Fisher et al. (2002) | 87 | 60 Gy RT with topotecan | Median survival 9 months |
Langer et al. (2001) | 61 | 60 Gy RT with paclitaxel | Median survival 10 months |